Triamcinolone Acetonide Extended-Release Injectable Suspension
19-3562
Phase 1 small_molecule completed
Quick answer
Triamcinolone Acetonide Extended-Release Injectable Suspension for Osteoarthritis, Knee is a Phase 1 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Osteoarthritis, Knee
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed